NDC 0409-1103 – Cisatracurium Besylate
Cisatracurium Besylate 10 mg/mL · Injection, Solution · Intravenous
Product NDC0409-1103
Product details
- Brand name
- Cisatracurium Besylate
- Generic name
- Cisatracurium Besylate
- Labeler
- Hospira, Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA203236
- Marketed since
- December 2, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- Nondepolarizing Neuromuscular Blocker
Active ingredients
- Cisatracurium Besylate 10 mg/mL
Uses, dosage, side effects and warnings for Cisatracurium Besylate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0409-1103-01 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1103-01) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-1103-11) | Dec 2, 2019 |
Other Cisatracurium Besylate products
- 83634-655 Cisatracurium Besylate 10 mg/mL · Injection, Solution · Avenacy, LLC
- 0409-1098 Cisatracurium Besylate 2 mg/mL · Injection, Solution · Hospira, Inc.
- 0409-1208 Cisatracurium Besylate 2 mg/mL · Injection, Solution · Hospira, Inc.
- 71288-714 Cisatracurium Besylate 20 mg/10mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 71288-713 Cisatracurium Besylate 200 mg/20mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 71288-712 Cisatracurium Besylate 10 mg/5mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 72485-513 Cisatracurium Besylate 200 mg/20mL · Injection · Armas Pharmaceuticals
- 31722-312 Cisatracurium Besylate 10 mg/mL · Injection · Camber Pharmaceuticals Inc.
- 31722-313 Cisatracurium Besylate 2 mg/mL · Injection · Camber Pharmaceuticals Inc.
- 31722-314 Cisatracurium Besylate 2 mg/mL · Injection · Camber Pharmaceuticals Inc.
- 65145-137 Cisatracurium Besylate 10 mg/mL · Injection · Caplin Steriles Limited
- 65145-136 Cisatracurium Besylate 2 mg/mL · Injection · Caplin Steriles Limited